A new independent analysis shows similar risks of blood clots in patients receiving Johnson & Johnson's Cypher stent and Boston Scientific Corp.'s Taxus stent, Boston Scientific said late on Monday.
But wait!
Johnson & Johnson says it is standing behind the safety of its Cypher drug-eluting stent in the face of mounting concern these treatments for clogged heart arteries may increase the risk of blood clots.
J&J said data presented at a meeting of cardiologists on Tuesday suggested there was no statistically significant difference between the risk of blood clots from the Cypher drug-eluting stent and the risk from older, bare-metal stents.
The data contradicted an analysis presented at a symposium Monday night sponsored by J&J's chief stent rival, Boston Scientific Corp.
So, that's cleared that up, then!
No?
So, who to believe?
How about eminent cadiologist Dr Salim Yusuf who described the rush to using drug eluting stents as "an epidemic of madness"!
No comments:
Post a Comment